183 related articles for article (PubMed ID: 20531306)
1. PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
Gkika D; Flourakis M; Lemonnier L; Prevarskaya N
Oncogene; 2010 Aug; 29(32):4611-6. PubMed ID: 20531306
[TBL] [Abstract][Full Text] [Related]
2. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function.
Bidaux G; Flourakis M; Thebault S; Zholos A; Beck B; Gkika D; Roudbaraki M; Bonnal JL; Mauroy B; Shuba Y; Skryma R; Prevarskaya N
J Clin Invest; 2007 Jun; 117(6):1647-57. PubMed ID: 17510704
[TBL] [Abstract][Full Text] [Related]
3. TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?
Zhang L; Barritt GJ
Endocr Relat Cancer; 2006 Mar; 13(1):27-38. PubMed ID: 16601277
[TBL] [Abstract][Full Text] [Related]
4. Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators.
Beck B; Bidaux G; Bavencoffe A; Lemonnier L; Thebault S; Shuba Y; Barrit G; Skryma R; Prevarskaya N
Cell Calcium; 2007 Mar; 41(3):285-94. PubMed ID: 16949669
[TBL] [Abstract][Full Text] [Related]
5. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement.
Bidaux G; Roudbaraki M; Merle C; Crépin A; Delcourt P; Slomianny C; Thebault S; Bonnal JL; Benahmed M; Cabon F; Mauroy B; Prevarskaya N
Endocr Relat Cancer; 2005 Jun; 12(2):367-82. PubMed ID: 15947109
[TBL] [Abstract][Full Text] [Related]
6. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
Bai VU; Murthy S; Chinnakannu K; Muhletaler F; Tejwani S; Barrack ER; Kim SH; Menon M; Veer Reddy GP
Int J Oncol; 2010 Feb; 36(2):443-50. PubMed ID: 20043080
[TBL] [Abstract][Full Text] [Related]
7. Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarcinoma cells.
Cucu D; Chiritoiu G; Petrescu S; Babes A; Stanica L; Duda DG; Horii A; Dima SO; Popescu I
Pancreas; 2014 Jul; 43(5):795-800. PubMed ID: 24658318
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.
Hsieh JT; Wu HC; Gleave ME; von Eschenbach AC; Chung LW
Cancer Res; 1993 Jun; 53(12):2852-7. PubMed ID: 7684949
[TBL] [Abstract][Full Text] [Related]
9. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
[TBL] [Abstract][Full Text] [Related]
10. Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines.
Okamoto Y; Ohkubo T; Ikebe T; Yamazaki J
Int J Oncol; 2012 May; 40(5):1431-40. PubMed ID: 22267123
[TBL] [Abstract][Full Text] [Related]
11. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
Ma S; G G; Ak VE; Jf D; H H
Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
[TBL] [Abstract][Full Text] [Related]
12. Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells.
Mergler S; Strowski MZ; Kaiser S; Plath T; Giesecke Y; Neumann M; Hosokawa H; Kobayashi S; Langrehr J; Neuhaus P; Plöckinger U; Wiedenmann B; Grötzinger C
Neuroendocrinology; 2007; 85(2):81-92. PubMed ID: 17426390
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.
Bindukumar B; Schwartz S; Aalinkeel R; Mahajan S; Lieberman A; Chadha K
Prostate; 2008 Oct; 68(14):1531-45. PubMed ID: 18646040
[TBL] [Abstract][Full Text] [Related]
14. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Paliouras M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
[TBL] [Abstract][Full Text] [Related]
15. TRPM8 and prostate: a cold case?
Noyer L; Grolez GP; Prevarskaya N; Gkika D; Lemonnier L
Pflugers Arch; 2018 Oct; 470(10):1419-1429. PubMed ID: 29926226
[TBL] [Abstract][Full Text] [Related]
16. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells.
Zhang L; Barritt GJ
Cancer Res; 2004 Nov; 64(22):8365-73. PubMed ID: 15548706
[TBL] [Abstract][Full Text] [Related]
17. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.
Louhivuori LM; Bart G; Larsson KP; Louhivuori V; Näsman J; Nordström T; Koivisto AP; Akerman KE
J Cell Physiol; 2009 Oct; 221(1):67-74. PubMed ID: 19507192
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
19. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
20. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
